West Wealth Group
EW icon

West Wealth Group’s Edwards Lifesciences EW Stock Holding History

West Wealth Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,261
Closed -$205K – 150
2026
Q2 		$205K Buy
+2,261
New +$189K 0.03% 142
2026
Q1 		– Sell
-2,360
Closed -$201K – 133
2025
Q4 		$201K Buy
+2,360
New +$194K 0.04% 126

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One North America
Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

West Wealth Group's EW Position: Q3 2026 in Review

West Wealth Group sold out of Edwards Lifesciences (EW) in Q3 2026, closing a stake of 2,261 shares — an estimated $205K sold.

West Wealth Group first reported a position in EW in Q4 2025 and held it in 2 quarters. The position peaked at $205K in Q2 2026. 328 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • West Wealth Group reported no remaining Edwards Lifesciences position as of Q3 2026 after selling out during the quarter.
  • West Wealth Group sold 2,261 Edwards Lifesciences shares in Q3 2026, an estimated $205K.
  • West Wealth Group first reported a position in Edwards Lifesciences in Q4 2025 and held it in 2 quarters.
  • West Wealth Group's Edwards Lifesciences position peaked at $205K in Q2 2026.
  • 328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on West Wealth Group's 13F filing for Q3 2026, filed 14 Oct 2026.